XML 25 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Segment Reporting Information [Line Items]      
Sale of Product $ 2,335,786 $ 2,527,852  
Depreciation and Amortization 74,617 64,985  
Segment Income (Loss) (422,494) (51,958)  
Expenditures for Segment Assets 1,565 5,084  
Segment Assets 17,158,384   $ 15,256,795
Radiochemical Products      
Segment Reporting Information [Line Items]      
Sale of Product 755,221 463,232  
Cobalt Products      
Segment Reporting Information [Line Items]      
Sale of Product 305,620 376,089  
Radiological Services      
Segment Reporting Information [Line Items]      
Sale of Product 72,321 587,609  
Fluorine Products      
Segment Reporting Information [Line Items]      
Sale of Product 160,500 0  
Operating Segments      
Segment Reporting Information [Line Items]      
Sale of Product 2,335,786 2,527,852  
Depreciation and Amortization 69,835 60,248  
Segment Income (Loss) 422,657 779,481  
Expenditures for Segment Assets 1,565 5,084  
Segment Assets 11,591,845   11,576,616
Operating Segments | Radiochemical Products      
Segment Reporting Information [Line Items]      
Sale of Product 755,221 463,232  
Depreciation and Amortization 10,354 8,817  
Segment Income (Loss) 5,619 96,006  
Expenditures for Segment Assets 0 0  
Segment Assets 536,603   511,381
Operating Segments | Cobalt Products      
Segment Reporting Information [Line Items]      
Sale of Product 305,620 376,089  
Depreciation and Amortization 8,761 1,080  
Segment Income (Loss) 123,796 192,870  
Expenditures for Segment Assets 0 3,494  
Segment Assets 3,388,527   3,369,828
Operating Segments | Nuclear Medicine Standards      
Segment Reporting Information [Line Items]      
Sale of Product 1,042,124 1,100,922  
Depreciation and Amortization 15,989 15,619  
Segment Income (Loss) 185,301 216,822  
Expenditures for Segment Assets 0 0  
Segment Assets 2,087,295   2,111,225
Operating Segments | Radiological Services      
Segment Reporting Information [Line Items]      
Sale of Product 72,321 587,609  
Depreciation and Amortization 8,636 8,636  
Segment Income (Loss) (14,929) 311,279  
Expenditures for Segment Assets 0 0  
Segment Assets 96,427   106,374
Operating Segments | Fluorine Products      
Segment Reporting Information [Line Items]      
Sale of Product 160,500 0  
Depreciation and Amortization 26,095 26,095  
Segment Income (Loss) 122,870 (37,495)  
Expenditures for Segment Assets 1,565 1,590  
Segment Assets 5,482,993   5,477,808
Corporate Allocation      
Segment Reporting Information [Line Items]      
Sale of Product 0 0  
Depreciation and Amortization 4,782 4,737  
Segment Income (Loss) (845,151) (831,439)  
Expenditures for Segment Assets 0 $ 0  
Segment Assets $ 5,566,539   $ 3,680,179